Antineutrophil cytoplasmic antibody-positive vasculitis in a patient with Graves disease: Cross-reaction between propylthiouracil and methimazole

Endocrine Practice

Volumn 16, Issue 3, 2010, Pages 449-451

  Ahmed, Khulood ^a   Rao, Sneha ^a   Simha, Vinaya ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ENZYME ANTIBODY; MYELOPEROXIDASE ANTIBODY; NARCOTIC ANALGESIC AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; PROPYLTHIOURACIL; PROTEINASE 3 ANTIBODY; RADIOACTIVE IODINE; THIAMAZOLE; THYROID PEROXIDASE ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG; ANTITHYROID AGENT;

ABLATION THERAPY; ADULT; ANCA ASSOCIATED VASCULITIS; ANTIBODY TITER; ARTHRALGIA; ARTICLE; CASE REPORT; DISEASE COURSE; DISEASE SEVERITY; DRUG CROSS REACTIVITY; DRUG DOSE INCREASE; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; EXOPHTHALMOS; FATIGUE; FEMALE; FREE THYROXINE INDEX; GOITER; GRAVES DISEASE; HEMATURIA; HISPANIC; HUMAN; HYPERTHYROIDISM; INFARCTION; LEUKOCYTOCLASTIC VASCULITIS; MYALGIA; PALPATION; PHYSICAL EXAMINATION; PROTEINURIA; PURPURA; RASH; RECURRENT DISEASE; SKIN DEFECT; TENDON REFLEX; THYROID SCINTISCANNING; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; URINALYSIS; WEIGHT REDUCTION; DRUG INTERACTION; METABOLISM; VASCULITIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTITHYROID AGENTS; DRUG INTERACTIONS; FEMALE; GRAVES DISEASE; HUMANS; METHIMAZOLE; PROPYLTHIOURACIL; VASCULITIS;

EID: 77956645992     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP09304.CR     Document Type: Article

References (22)

1. Chen B, Lang R, Jutrin Y, Ravid M. Recurrent agranulocytosis induced by two different anti-thyroid agents. Med J Aust. 1983;2:38-39.
2. Wing SS, Fantus IG. Adverse immunologic effects of antithyroid drugs. CMAJ. 1987;136:121-127. (Pubitemid 17004952)
3. Ostlere S, Apthorp GH. Recurrent agranulocytosis following carbimazole and propylthiouracil therapy. Br J Clin Pract. 1988;42:474-475.
4. Stankus SJ, Johnson NT. Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest. 1992;102:1595-1596.
5. Aloush V, Litinsky I, Caspi D, Elkayam O. Propylthiouracil-induced autoimmune syndromes: Two distinct clinical presentations with different course and management. Semin Arthritis Rheum. 2006;36:4-9. (Pubitemid 44144499)
6. Chen YX, Yu HJ, Ni LY, et al. Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: Retrospective study of 19 cases. J Rheumatol. 2007;34:2451-2456.
7. Gao Y, Chen M, Ye H, Yu F, Guo XH, Zhao MH. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis. Rheumatology (Oxford). 2008;47:1515-1520.
8. Noh JY, Yasuda S, Sato S, et al. Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs. J Clin Endocrinol Metab. 2009;94:2806-2811.
9. Yazisiz V, Ongüt G, Terzioǧlu E, Karayalçin U. Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment. Int J Clin Pract. 2010;64:19-24.
10. Cin MO, Gursoy A, Morris Y, Aydintug OT, Kamel N, Gullu S. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil. Int J Clin Pract. 2009;63:299-302.
11. Ohtsuka M, Yamashita Y, Doi M, Hasegawa S. Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody. Eur Respir J. 1997;10:1405-1407. (Pubitemid 27278267)
12. Batchelor N, Holley A. A fatal case of propylthiouracil-induced ANCA-positive vasculitis. MedGenMed. 2006;8:10.
13. Irani F, Elkambergy H, Naraharisetty K, Jamal R. Propylthiouracil-induced leucocytoclastic vasculitis with pulmonary hemorrhage treated with plasmapheresis. Am J Med Sci. 2009;337:470-472.
14. Dhillon SS, Singh D, Doe N, Qadri AM, Ricciardi S, Schwarz MI. Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil. Chest. 1999;116:1485-1488. (Pubitemid 29536015)
15. Yamashita Y, Yamane K, Fujikawa R, Okubo M, Kohno N. A successful pregnancy and delivery case of Graves' disease with myeloperoxidase antineutrophil cytoplasmic antibody induced by propylthiouracil. Endocr J. 2002;49:555-559. (Pubitemid 35334002)
16. Kang AY, Baek YH, Sohn YJ, et al. Diffuse alveolar hemorrhage associated with antineutrophil cytoplasmic antibody levels in a pregnant woman taking propylthiouracil. Korean J Intern Med. 2006;21:240-243.
17. Seo P. Pregnancy and vasculitis. Rheum Dis Clin North Am. 2007;33:299-317. (Pubitemid 46722669)
18. Reidy TJ, Upshaw JD Jr, Chesney TM. Propylthiouracil-induced vasculitis: A fatal case. South Med J. 1982;75:1297-1298. (Pubitemid 13224672)
19. Takuwa N, Kojima I, Ogata E. Lupus-like syndrome - a rare complication in thionamide treatment for Graves' disease. Endocrinol Jpn. 1981;28:663-667. (Pubitemid 13147802)
20. Wall JR, Fang SL, Kuroki T, Ingbar SH, Braverman LE. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: A possible cause of antithyroid drug-induced agranulocytosis. J Clin Endocrinol Metab. 1984;58:868-872. (Pubitemid 14102110)
21. Harper L, Cockwell P, Savage CO. Case of propylthiouracil-induced ANCA associated small vessel vasculitis. Nephrol Dial Transplant. 1998;13:455-458. (Pubitemid 28062213)
22. Erem C, Yucel Y, Ya Z, Reis A, Kocak M, Hacihasanoglu A. Leukocytoclastic vasculitis: A rare manifestation of propylthiouracil hypersensitivity. Med Princ Pract. 2005;14:366-369. (Pubitemid 41161015)